NOVONIX Balance Sheet Health
Financial Health criteria checks 4/6
NOVONIX has a total shareholder equity of $183.9M and total debt of $64.6M, which brings its debt-to-equity ratio to 35.1%. Its total assets and total liabilities are $263.3M and $79.4M respectively.
Key information
35.1%
Debt to equity ratio
US$64.56m
Debt
| Interest coverage ratio | n/a |
| Cash | US$78.71m |
| Equity | US$183.94m |
| Total liabilities | US$79.41m |
| Total assets | US$263.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GC30's short term assets ($89.2M) exceed its short term liabilities ($7.8M).
Long Term Liabilities: GC30's short term assets ($89.2M) exceed its long term liabilities ($71.6M).
Debt to Equity History and Analysis
Debt Level: GC30 has more cash than its total debt.
Reducing Debt: GC30's debt to equity ratio has increased from 24.1% to 35.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GC30 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GC30 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 51.9% each year